Jeffrey A. Meyerhardt, MD, MPH, FASCO

Cancer.Net Associate Editor: Gastrointestinal (GI) Cancers
Dana-Farber Cancer Institute, Boston, MA

Dr. Jeffrey Meyerhardt is the Douglas Gray Woodruff Chair in Colorectal Cancer Research,  Clinical Director and Senior Physician at the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute (DFCI), Deputy Clinical Research Officer at DFCI, and Professor of Medicine at Harvard Medical School. He received his medical degree from Yale School of Medicine in 1997 and completed a residency in internal medicine at Beth Israel Deaconness Medical Center, in Boston, followed by a medical oncology fellowship at DFCI. He also holds a Masters of Public Health from Harvard School of Public Health in Boston.

Dr. Meyerhardt’s research focuses on the impact of diet and lifestyle on outcomes among people diagnosed with colorectal cancer. He is the principal investigator for an ongoing National Cancer Institute-sponsored clinical trial on adjuvant therapy for stage III colon cancer. He is a co-chair of the Gastrointestinal Cancer committee of the Alliance for Clinical Trials in Oncology, and a member of the National Clinical Trials Network of the National Cancer Institute. 

Dr. Meyerhardt is an active member of ASCO, serving on multiple committees including the Clinical Practice Guidelines Committee, Conquer Cancer Foundation Grants Selection Committee, Annual Meeting Scientific Program Committee and Cancer Education Committee. He is also a member of the Editorial Board for the Journal of Clinical Oncology (JCO) and has co-edited two special series for the JCO on Energy Balance and Cancer and on Gastrointestinal Cancers.

View current ASCO disclosure here.

Last updated: August 2018